✦ LIBER ✦

Molecular pathology of Breast Cancer: Prognostic and predictive markers in this century and the next

✍ Scribed by Diana M. Barnes

Publisher: Springer Japan
Year: 1999
Tongue: English
Weight: 653 KB
Volume: 6
Category: Article
ISSN: 1340-6868
DOI: 10.1007/bf02966439

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic and predictive factors in the

Prognostic and predictive factors in the adjuvant treatment of breast cancer

✍ Takashi Fukutomi; Sadako Akashi-Tanaka 📂 Article 📅 2002 🏛 Springer Japan 🌐 English ⚖ 573 KB

Proliferation is the strongest prognosti

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

✍ Jan P. A. Baak; Einar Gudlaugsson; Ivar Skaland; Lydia Hui Ru Guo; Jan Klos; Ton 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 537 KB

The prognostic and predictive values of

The prognostic and predictive values of circulating HER-2/neuextracellular domain in patients with metastatic breast cancer

✍ Maysa M. Abu-Khalaf; Lyndsay Harris 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 135 KB

Utility of cytologic specimens in the ev

Utility of cytologic specimens in the evaluation of prognostic and predictive factors of breast cancer: Current issues and future directions

✍ Nour Sneige 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 730 KB

Comparison of the metastasis-inducing pr

Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer

✍ Angela M. Platt-Higgins; Christine A. Renshaw; Christopher R. West; John H.R. Wi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 293 KB 👁 1 views

Our aim was to compare the occurrence and prognostic significance over 14 -20 years of immunocytochemically detected S100A4 and other tumour variables in primary tumours from 349 patients with operable breast cancer. For a cut-off of 1% staining of the malignant cells, the antibody to S100A4 stains

Tumor angiogenesis as prognostic and pre

Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial

✍ Oleg Gluz; Peter Wild; Cornelia Liedtke; Ronald Kates; Heiko Mendrik; Elisabeth 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 372 KB